Bristol Myers Squibb Beats Earnings Estimates and Raises Outlook Amid Cost-Cutting Measures
Bristol Myers Squibb reported strong second-quarter earnings, surpassing Wall Street expectations and raising its full-year guidance as part of its broader strategy to cut costs and...